F

Franciscan Health | Indiana Blood and Marrow Transplantation

Research site
(Unclaimed)
Location
8111 S. Emerson Avenue Suite 207, Indianapolis, Indiana, United States of America
Site insights

Top conditions

Leukemia (8 trials)

Myeloid Leukemia (5 trials)

Lymphoma (5 trials)

BCR-ABL Positive Chronic Myelogenous Leukemia (4 trials)

Non-Hodgkin Lymphoma (3 trials)

Top treatments

Bosutinib
Ruxolitinib
INCB050465
Gemcitabine
methylprednisolone
Decitabine
tacrolimus
Ibrutinib
VRx-3996
IMPT-314

Parent organization

This site is a part of Franciscan Health

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 19
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL (EPCORE DLBCL-1)

The drug that will be investigated in the study is an antibody, epcoritamab, also known as EPKINLY™ and GEN3013. Since the safety and tolerability of...

Active, not recruiting
Diffuse Large B-cell Lymphoma
Drug: Investigator's Choice Chemotherapy
Biological: Epcoritamab

The purpose of this single-arm, open-label, Phase 1b/2a, multicenter basket study is to evaluate whether tafasitamab and parsaclisib can be safely co...

Active, not recruiting
Chronic Lymphocytic Leukemia
Non Hodgkin Lymphoma
Drug: tafasitamab
Drug: parsaclisib

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...

Enrolling
Relapsed Non-Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma
Drug: IMPT-314

Trial sponsors

Incyte logo

Incyte (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems